Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report

Peer Review reports

Original Submission
24 Oct 2019	Submitted	Original manuscript
25 Nov 2019	Reviewed	Reviewer Report - Tayfur Toptas
2 Dec 2019	Reviewed	Reviewer Report - Tugrul Elverdi
9 Dec 2019	Author responded	Author comments - Yao-Chung Liu
8 Jan 2020	Author responded	Author comments - Yao-Chung Liu
Resubmission - Version 2
9 Dec 2019	Submitted	Manuscript version 2
Publishing
20 Feb 2020	Editorially accepted
17 Mar 2020	Article published	10.1186/s13256-020-02363-3

Back to article page